We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biomarkers for Drug-Induced Kidney Injury Get Boost From EMA, FDA
Biomarkers for Drug-Induced Kidney Injury Get Boost From EMA, FDA
The European Medicines Agency is lending support to an initiative to qualify biomarkers that can provide early warning of an investigational compound’s risks of causing drug-induced kidney injuries.